Flucelvax

INFLUENZA A VIRUS A/Tasmania/318/2025 CVR-351 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Tasmania/787/2025 CVR-388 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Arizona/21/2025 ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED) · Injection, Suspension · Intramuscular

Prescription (Rx)

No FDA structured label text is available for Flucelvax. The NDC listings below come from the FDA National Drug Code directory.

Active ingredients

Flucelvax NDC products (4)

NDCStrength & formLabelerType
87063-299Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL;…
Injection, Suspension
ASCLEMED USA INC.BLA
83703-088Influenza A Virus A/georgia/12/2022 Cvr-167 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL;…
Injection, Suspension
Bamboo US BidCo LLCBLA
70461-656Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL;…
Injection, Suspension
Seqirus Inc.BLA
85766-263Influenza A Virus A/tasmania/318/2025 Cvr-351 (h1n1) Antigen (mdck Cell Derived, Propiolactone Inactivated) 15 ug/.5mL;…
Injection, Suspension
Sportpharm LLCBLA

Frequently asked questions

Who makes Flucelvax?

Flucelvax is listed by 4 labelers in the FDA NDC directory, including ASCLEMED USA INC., Bamboo US BidCo LLC, Seqirus Inc., Sportpharm LLC.